Abstract: As part of our search for bioactive compounds from plant biodiversity, 29 withanolides were recently isolated from three members of the Solanaceae: Physalis longifolia, Vassobia breviflora, and Withania somnifera. Six derivatives were prepared from these naturally occurring withanolides. All compounds were evaluated for in vitro antiproliferative activity against an array of cell lines [melanoma cell lines (B16F10, SKMEL28); human head and neck squamous cell carcinomas (HNSCC) cell lines (JMAR, MDA1986, DR081-1); breast cancer cell line (Hs578T), and non-malignant human cell line (MRC5)]. This led to the discovery of 15 withanolides, with IC 50 values in the range of 0.067−17.4 μM, including withaferin A, withaferin A 4,27-diacetate, 27-O-glucopyranosylwithaferin A, withalongolide H, withalongolide C, withalongolide A, withalongolide A 4,27-diacetate, withalongolide A 4,19,27-triacetate, withalongolide B, withalongolide B 4-acetate, withalongolide B 4,19-diacetate, withalongolide D, withalongolide E, withalongolide G, and 2,3-dihydrowithaferin A 3-O-sulfate. In order to update the growing literature on withanolides and their activities, we summarized the distribution, structural types, and antiproliferative activities for all published withanolides to date. The structure-activity relationship analysis (SARA) confirmed the importance of the presence of a Δ 2 -1-oxo-functionality in ring A, a 5β,6β-epoxy or 5α-chloro-6β-hydroxy grouping in ring B, and nine-carbon side chain with a lactone moiety for cytotoxic activity. Conversely, the SARA indicated that the -OH or -OR groups at C-4, 7, 11, 12, 14, 15, 16, 17, 18, 19, 20, 23, 24, 27, and 28 were not contributors to the observed antiproliferative activity within the systems analyzed.
INTRODUCTION
The name "withanolides" was originally given to a family of C 28 ergostane-type steroidal δ-lactones (derived from a parent 22-hydroxy-26-oic acid) isolated from the genus Withania (Solanaceae). The term "withan" refers to Withania and "-olide" to the presence of lactone functionality in this type of compound. With the structural elucidation of withaferin A 1 ( Fig. 1 ) in 1965, a new area of withanolide chemistry was initiated [1] . Further investigations in this field led to the discovery of many hun- (continues on next page) Type I withanolides ( Fig. 2) , also called unmodified withanolides, are the most abundant form found in nature. With approximately 540 compounds in this category reported to date, they are distributed in the majority of the genera listed in Table 1 . From the biogenetic origin, it is likely that type I compounds are precursors to the more advanced structural types II−XXII. Type I withanolides that display the most promising antiproliferative characteristics also contain Δ 2 -1-oxo-functionality in ring A, a 5β,6β-epoxy-group in ring B, and a nine-carbon side chain incorporating the δ-lactone functionality found in withaferin A 1 [17] , withacnistin 59 [18, 19] , withanolide D 48 [20] [21] [22] [23] , withanolide E 36 [8, [24] [25] [26] [27] , and 4β-hydroxywithanolide E 37 (Fig. 4) [8, [24] [25] [26] [27] . Withaferin A 1 (Fig. 1 ) was shown to induce apoptosis in vitro and in vivo by suppressing the growth of an array of tumor cells, including breast, pancreatic, prostate, lung, leukemia, as well as various head and neck squamous cell carcinomas (HNSCCs) [17] . This compound has the potential for development as an antiproliferative agent.
As part of our continuing investigations to discover drug leads from plant biodiversity, we have explored the antiproliferative potential of compounds present in several members of the large family Solanaceae. Fig. 3 ). Of these, 29 withanolides (1, 3-6, 9, 12-18, and 20-35) were isolated from the three taxa investigated whereas the remaining six analogues (2, 7, 8, 10, 11, and 19) were prepared from the naturally occurring compounds (1, 6, and 9). In this report, we provide a summary of the withanolide chemistry and anti proliferative results obtained during our studies [17, 28, 29] and attempt to provide a structure-activity relationship analysis (SARA) in comparison with published data in the literature for other withanolides with antiproliferative activity.
RESULTS AND DISCUSSION
Our own investigation of selected members of the Solanaceae afforded withanolides 1, 20, and 22 from the aerial parts of Vassobia breviflora [17] , withanolides 1, 14, 17, 18, and 24-30 from the leaves of Withania somnifera [28] , as well as withanolides 1, 3-6, 9, 12, 13, 15-18, 20-23, and 31-35 from the aerial part of Physalis longifolia [29] . The acetate derivatives 7 and 8 were prepared from withalongolide A 6; compounds 10 and 11 were obtained from withalongolide B 9 while compounds 2 and 19 were derived from withaferin A 1. Withanolides 13-17 are likely to be artifacts formed during the isolation process. The structures of 1-35 were determined by electrospray ionization-mass spectrometry (ESI-MS) and 2D NMR experiments while those of 5, 6, 9, 13, 19, and 28 [28, 29] were confirmed by X-ray crystallographic analysis.
Based on their carbon skeletons, the withanolides isolated by our group can be assigned to four structural types with various degrees of oxygenation: type I (1-12, and 15-30), type VIII (31-35), type XI (13), and type XII (14) . All the compounds show the commonly oxygenated carbons at C-1, 22, and 26 except compound 35 which lacks an oxygenated C-1. All 35 withanolides isolated during our studies were tested against the HNSCC cells (JMAR, MDA1986, and DR081-1), melanoma cells (B16F10 and SKMEL28), and/or breast cancer cells (Hs578T) as well as non-malignant human renal epithelial cells (MRC5) for their in vitro antiproliferative activities. Cisplatin was used as a positive control. The results, expressed as IC 50 (50 % inhibition of cell growth), are summarized in Table 2 . Overall, 15 withanolides (1-11, 16-17, and 21-22) including the five acetate derivatives (2, 7, 8, 10, and 11) showed antiproliferative effects against the cells tested with IC 50 values in the range 0.067−17.4 μM, while the other withanolides were inactive when tested at the higher concentration of 20 μM. A preliminary structure-activity relationship (SAR) could be inferred based on the assay data obtained. Direct comparison revealed that opening of the 5β,6β-epoxy-group of withaferin A 1 to furnish the corresponding 5β,6α-diol 29 or 6α-chloro-5β-ol 30 resulted in loss of activity. These findings confirm that the 5β,6β-epoxy-group in ring B is essential for the observed cytotoxic activity, in agreement with results previously reported in the literature for compounds with similar structural features [25] [26] [27] .
Withanolides 15-22 contain a 5β,6β-epoxy-group in ring B but lack a Δ 2 -1-oxo-system in ring A. A loss of activity was observed when this latter feature is absent, by comparing activity of withaferin A 1 with 2,3-dihydrowithaferin A 18 or 2,3-dihydro-27-deoxywithaferin A 19, or 2,3-dihydro-3β-hydroxywithaferin A 20. A decrease of activity was also observed when Δ 2 -1-oxo-functionality was replaced with a 2,3-dihydro-3β-methoxy moiety, by comparing withaferin A 1 with 2,3-dihydro-3β-methoxywithaferin A 17, and withalongolide B 5 with 2,3-dihydro-3β-methoxywithalongolide C 15. On the other hand, the activity observed for 2,3-dihydrowithalongolide A 3β-O-sulfate 21 and 2,3-dihydrowithaferin A 3β-O-sulfate 22 was likely due to their spontaneous conversion in the cell culture media to the corresponding withalongolide A 6 and withaferin A 1, both compounds having Δ 2 -1-oxo-functionality [30] . Our data thus confirm the significance of the presence of this ring A feature for the observed cytotoxic activity and are in agreement with results available in the literature [24, 26] .
As in the case of withaferin A 1, withanolides 2-11 with identical functionality in rings A and B were also active, further supporting the significance of this functional array. In contrast, withanolides 12-14 and 23-35, in which it is absent, were shown to be inactive.
Furthermore, withaferin A 1, 27-O-glucopyranosylwithaferin A 3, and 27-O-[α-L-rhamnopyranosyl(1 → 4)]-glucopyranosylwithaferin A 4, in which the combination of 5β,6β-epoxy-and Δ 2 -1-oxofunctionality is retained, showed different activities against the cells tested. Withanolide glycoside 3 with one sugar residue was less active relative to the aglycone 1, while withanolide saponin 4 with two sugar residues displayed less cytoxicity when compared to 3. This observation suggested that glycosylation of withanolides resulted in a decrease of cytotoxic activity. On the other hand, esterification of the hydroxyl groups at C-4, C-19, and C-27 increased cytotoxicity when comparing withaferin A 1 with withaferin A 4,27-diacetate 2; withalongolide A 6 with withalongolide A 4,27-diacetate 7 and withalongolide A 4,19,27-triacetate 8; withalongolide B 9 with withalongolide B 4-acetate 10 and withalon-H. ZHANG et al. (Table 2) . These results are in agreement with previously reported SARs [24] [25] [26] [27] 31] . It should be noted that the cytotoxic activity of withalongolide B 9 is comparable to that of withaferin A 1, while the triacetate derivative 8 and diacetate derivative 11 are more potent than withaferin A 1 by exhibiting submicromolar activity with IC 50 values in the range of 0.067-0.91 μM against all the cell lines tested.
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All withanolides so far discovered can be generally defined as poly-oxygenated steroids with all their carbon atoms bearing oxygen functions except for C-8 and C-10. Scattered throughout the literature, it is apparent by qualitative measures, that the -OH or -OR groups do not contribute to the antiproliferative ability of the active withanolides. This characteristic has been observed with different cell lines used in the evaluation of cytotoxicity for this type of compound. Various withanolides containing hydroxyl groups at different positions were assembled from the literature (Fig. 4) and listed in Table 3 for a comparison of their respective cytotoxic activities. It is clear from these data that hydroxy-or acetoxy-groups at C-4, 7, 11, 12, 14, 15, 16, 17, 18, 19, 20, 23, 24 , and 27 have no significant effect on their cytotoxic activity. In most cases, withanolides possessing hydroxyl groups at such positions are slightly less potent than those without this functional group. The results of the analysis based on our own data as well as those obtained from the literature (Table 3) are summarized below, taking into consideration different functional groups in the withanolide molecules:
4-OH group: The presence of a 4β-hydroxy-group is not required for the cytotoxic activity when comparing the activity of withanolide E 36 and 4β-hydroxywithanolide E 37 [24, 26, 27 ]; 4-deoxy-7,16-diacetoxywithanolide D 39 and 7,16-diacetoxywithanolide D 40 [32] ; 4-deoxyphysagulin C 42 and physagulin C 43 [33] ; 4-deoxywithangulatin A 44 and withangulatin A 45 [33] ; acnistin A 46 and 4-hydroxyacnistin E 47 [34] . In most cases, the 4-hydroxywithanolides are slightly less potent than the corresponding 4-deoxywithanolides.
7-OAc group:
The presence of 7β-acetoxy-group had essentially no effect on the cytotoxic activity when comparing the activity of withanolides D 41 and 40 [32] .
11-OH group: 11β-Hydroxywithaferin A 5 is slightly less potent than withaferin A 1 ( Table 2) . 12-OH group: 12β-Hydroxywithanolide D 49 is slightly less potent than withanolide D 48 [22] . 14,15-epoxy-group: 14α,15α-Epoxywithaferin A 50 is less potent than withaferin A 1 [35] . 16-OH group: 16α-Hydroxyanomanolide A 52 is slightly less potent than anomanolide A 51 [36] .
16-OAc group: 7β,16α-Diacetoxywithanolide D 40 is slightly less potent than 7β-acetoxywithanolide D 41 [32, 37] .
16,17-epoxy-group: 16α,17α-Epoxywithaolide D 55 is slightly less potent than withanolide D 48 [36] .
17-OH group: 17α-Hydroxywithanolide D 56 is slightly less potent than withanolide D 48 [36] . 18-OAc group: 18-Acetoxy-27-deoxywithaferin A 58 is comparable to withaferin A 1 [18] .
19-OH group:
19-Hydroxywithaferin A 6 is less potent than withaferin A 1. 2,3-dihydro-19-hydroxywithaferin A 3β-O-sulfate 22 is less potent than 2,3-dihydrowithaferin A 3β-O-sulfate 21. 4,27-Diacetoxy-19-hydroxywithaferin A 7 is comparable to 4,27-diacetoxywithaferin A 2 ( Table 2) . In most cases, the 19-hydroxywithanolides are slightly less potent than the corresponding 19-deoxywithanolides.
20-OH group: 20-Hydroxytubocapsanolide F 56 is comparable to tubocapsanolide F 57 while 20-hydroxytubocapsanolide A 55 is slightly less potent than tubocapsanolide A 53 [36] .
23-OH group: 23-Hydroxytubocapsanolide A 54 is slightly less potent than tubocapsanolide A 53 [36] .
24-OH group: 24-Hydroxywithaphysacarpin 60 is less potent than withaphysacarpin 59 [38] . 27-OH group: 27-Hydroxy withalongolide B 6 is less potent than withalongolide B 9 ( Table 2) . It should be noted that although there are several 21-hydroxywithanolides (mainly isolated from Datura [39] and Jaborosa [5] ) and 28-hydroxywithanolides reported in the literature, their antiprolifer- ative screening data are not available in order to evaluate the significance of the presence of the -OH or -OR groups at such positions. In addition, it has been reported that when the 5β,6β-epoxy moiety in ring B is replaced by 5α-chloro-6β-hydroxy-functionality, the cytotoxicity of the two withanolides was comparable and in most cases the activity increased in the presence of the latter functional array. Several pairs of withanolides were compared for their activities, and similar results could be found in the literature: withanolide C 61 and withanolide E 36 [26] ; physagulin I 62 and physagulin H 42 [38] ; physagulin B 63 and 4-deoxy-withangulatin A 44 [38] ; physagulin B 63 and withangulatin 45 [40] ; and trechonolide A 64 and jaborosalactone 42 65 [27] .
Side chain: Withaferin A 1, withanolide D 48, withanolide E 36, and 4β-hydroxywithanolide E 37 bearing a δ-lactone in the nine-carbon side chain are more cytotoxic than the synthetic analogue, 5,6β-epoxy-4β-hydroxy-5β-cholest-2-en-1-one 66 [24] . Tubocapsanolide F 57 with a δ-lactone in the side chain was shown to be more potent than anomanolide A 67 with a type XIV skeleton [36] , suggesting the importance of a δ-lactone in order to retain cytotoxic potency.
Structural types: 4β,14α-Dihydroxywithanolide E 38 with an unmodified skeleton was more potent than physalin F 68 with a type XIX skeleton and physanolide A with a type XVII framework [25] . Withanolide E 36 was more potent than jaborosalactone 1 69 with a type XVI skeleton. Tubocapsenolide A 70 with a δ-lactone in the side chain showed strong cytotoxicity comparable to that of withanolide D 48 [36] . From these observations, it seems that type I withanoides with a lactone present in the nine-carbon side chain showed the most potent cytotoxic activity among the diverse variants discussed here.
In summary, the SARA derived from our own study and from data obtained from the literature confirmed that the 5β,6β-epoxy-group or 5α-chloro-6β-hydroxy-functionality in ring B, and conjugated Δ 2 -1-oxo-functionality in ring A are the important requirements for the enhancement of antiproliferative activities in various cell systems. The unmodified type I withanolides showed more potent cytotoxicity than the other structural types analyzed to date. Based on these observations, it is suggested that the -OH or -OR groups at C-4, 7, 11, 12, 14, 15, 16, 17, 18, 19, 20, 23, 24 , and 27 are non-contributors to the antiproliferative activity. In most cases, withanolides possessing -OH or -OR groups at such positions are slightly less potent than those lacking the -OH or -OR groups. Furthermore, glycosylation of withanolides decreased the cytotoxic effect while esterification of the hydroxyl groups reversed the effect by increasing cytotoxicity (Fig. 5) . 
